Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, ...
4h
Hosted on MSNTop start-up accelerators for tech companies in 2025Top start-up accelerators for tech companies in 2025Issued by Emerging SoftwareJohannesburg, 14 Feb 2025Visit our press officeStart-up accelerators are intensive, short-term programmes designed to ...
Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...
In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...
For context, tech giants still top the global wealth charts. Elon Musk is by far the richest man in the world, with a total ...
We recently published a list of 10 Best Mid-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...
When done safely and securely, automated inbound engagement can provide significant benefits for pharmaceutical companies.
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Setting new standards for large format 3D printing Argo 1000 Hypermelt is the world's largest pellet-based 3D printer, ...
Texas now has 16 schools — including medical centers — reaching the elite R1 Carnegie classification under a revamped system.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results